Posted inCanadian News Education health
Doctor hails Canada’s first drug that slows Alzheimer’s disease
A recently approved Alzheimer's medication, lecanemab, is hailed as groundbreaking for its ability to slow disease progression. Available in over 50 countries, it changes treatment strategies, enhancing the quality of life for mild Alzheimer’s patients despite potential side effects.
